Botanical species · safety record

Eranthis hyemalis

The EFSA Compendium of Botanicals holds 4 constituent measurements and 1 adverse-effect record for Eranthis hyemalis. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Eranthis hyemalis (L.) Salisb.

4Constituent measurements

1Safety records

5Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Cardiac glycosides	Unspecified	—	—	Unspecified	Resolve DOI
Eranthin	Unspecified	—	—	Unspecified	Resolve DOI
Corytuberine	Live plants	Solvent extraction	—	Chromatographic tests	No resolvable identifier
Lectins	Roots and other underground parts	Solvent extraction	3 Percent	Chromatographic tests	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Pulmonary and cardiac	Respiratory	Unspecified	Fresh	Dog (as animal)	Case report	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Grunwald, D., Lutkefels, E., Wohlsein, P. Intoxication of a dog with winter aconite (Eranthis hyemalis). Kleintierpraxis, 2002, vol. 47, no. 10, p. 587-+.
CAMMUE, BP., PEETERS, B., PEUMANS, WJ. ISOLATION AND PARTIAL CHARACTERIZATION OF AN N-ACETYLGALACTOSAMINE-SPECIFIC LECTIN FROM WINTER-ACONITE (ERANTHIS-HYEMALIS) ROOT TUBERS . Biochemical journal, 1985, vol. 227, no. 3, p. 949-955.
Bruder, Marjorie., Haseler, Paul L., Muscarella, Marina., Lewis, William., Moody, Christopher J. Synthesis of the Oxepinochromone Natural Products Ptaeroxylin (Desoxykarenin), Ptaeroxylinol, and Eranthin . Journal of organic chemistry, 2010, vol. 75, no. 2, p. 353-358. DOI
Turker, A. U., Usta, C. Biological screening of some Turkish medicinal plant extracts for antimicrobial and toxicity activities . Natural product research, 2008, vol. 22, no. 2, p. 136-146. DOI
Slavik, Jiri., Bochorakova, Jitka., Slavikova, Leonora. Occurrence of magnoflorine and corytuberine in some wild or cultivated plants of Czechoslovakia. Collection of czechoslovak chemical communications, 1987, vol. 52, no. 3, p. 804-11.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature